FDG-PET parameters predict for recurrence in anal cancer – results from a prospective, multicentre clinical trial

Michael Peter Jones,George Hruby,Ur Metser,Swetha Sridharan,Anne Capp,Mahesh Kumar,Sarah Gallagher,Natalie Rutherford,Carl Holder,Christopher Oldmeadow,Jarad Martin

FDG-PET parameters predict for recurrence in anal cancer – results from a prospective, multicentre clinical trial

2019

Michael Peter Jones
George Hruby
Ur Metser
Swetha Sridharan
Anne Capp
Mahesh Kumar
Sarah Gallagher
Natalie Rutherford
Carl Holder
Christopher Oldmeadow
Jarad Martin

Background To investigate the prognostic significance of positron emission tomography (PET) parameters from F-18 fluorodeoxyglucose (FDG) PET scans performed pre- and post- chemo-radiotherapy (CRT) for squamous cell carcinoma of the anal canal (AC).

Keywords:

Clinical trial
Radiology
Carcinoma
Radiation therapy
Positron emission tomography
Anal cancer
Medicine
Fluorodeoxyglucose
Anal canal
Chemo-radiotherapy
Standardized uptake value
Logistic regression
Median follow-up

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations